{"audit":{"version":"1.5","generated_at":"2026-11-22T17:50:21.304790+00:00","generated_by":"Agenstry","report_url":"https://agenstry.com/agents/api.rare-disease-atlas.workers.dev","methodology_url":"https://agenstry.com/methodology","verifier_jwks_url":"https://agenstry.com/.well-known/jwks.json","subject":{"domain":"api.rare-disease-atlas.workers.dev","name":"Rare Disease Venture Atlas Agent","url":"https://api.rare-disease-atlas.workers.dev/a2a"}},"identity":{"provider":{"organization":"Rare Disease Venture Atlas","url":"https://rare-disease-atlas.github.io"},"registry_verification":null,"signature":{"signed":false,"signature_valid":null}},"protocol":{"version":"0.3.0","supports_streaming":false,"supports_push_notifications":false},"operational":{"live_state":"live","live_responds":true,"last_status_code":200,"last_elapsed_ms":59,"last_error":null},"track_record":{"first_seen":"2026-11-22T14:47:42.790717+00:00","last_checked":"2026-11-22T14:47:42.790717+00:00","last_seen_ok":"2026-11-22T14:47:42.790717+00:00","checks_total":1,"checks_ok":1,"uptime_pct":100.0,"uptime_window_days":30,"uptime_probes":1,"archived":false,"archived_reason":null},"conformance":{"score":59,"grade":"D","summary":"D-grade: significant issues, auth-gated, partially broken, or stale.","criteria":[{"key":"valid_card","label":"Valid AgentCard","points":10,"max_points":10,"status":"pass","detail":"Parseable AgentCard returned by the well-known endpoint (Agenstry readiness signal; not an official TCK certification)."},{"key":"live_responds","label":"Live JSON-RPC","points":25,"max_points":25,"status":"pass","detail":"Endpoint responds to a negotiated A2A SendMessage probe (answers in ~387 ms)."},{"key":"protocol_version","label":"Protocol version","points":5,"max_points":10,"status":"partial","detail":"Declares pre-1.0 A2A 0.3.0 (Google preview). Upgrade to v1.x for full points."},{"key":"signature","label":"JWS signature","points":0,"max_points":10,"status":"info","detail":"Card is unsigned (most published agents are)."},{"key":"uptime","label":"Uptime track record","points":0,"max_points":15,"status":"info","detail":"Only 1 probe so far, need ≥5 for an uptime grade."},{"key":"skills","label":"Skill declaration","points":10,"max_points":10,"status":"pass","detail":"Declares 8 skills with structured metadata."},{"key":"verified_identity","label":"Verified Identity","points":5,"max_points":10,"status":"partial","detail":"Provider declared: Rare Disease Venture Atlas (https://rare-disease-atlas.github.io). Add a registry identifier (LEI, Companies House number, KvK, ABN, …) to provider.legalEntity for full verified-business credit."},{"key":"freshness","label":"Freshness + modern flags","points":4,"max_points":5,"status":"pass","detail":"seen in upstream source within 0d"},{"key":"security","label":"Security declaration","points":0,"max_points":5,"status":"info","detail":"Neither securitySchemes nor securityRequirements declared — how to authenticate is unstated."}]},"card_read":{"findings":[],"clean":true,"source_url":"https://api.rare-disease-atlas.workers.dev/a2a"},"skills":[{"id":"search-orphan-venture-wedges","name":"Search Orphan Disease Startup Blueprints (Myelofibrosis-Anchored)","description":"Searches startup blueprints anchored on Clonal JAK2 V617F+ Myelofibrosis and Reversible Autoimmune Myelofibrosis (plus VEXAS, Castleman, Mastocytosis, and Telomere cohorts) by founder track, capital tier, and wet-lab requirement.","tags":["myelofibrosis","rare-disease","venture","biotech","ai-bio","public-health"],"examples":["Search zero-wet-lab computational AI/ML startup wedges under $250K seed budget.","What public-health diagnostic wedges exist for misdiagnosed myelofibrosis?"],"inputModes":[],"outputModes":[]},{"id":"jak2-clonal-myelofibrosis-diligence","name":"Clonal JAK2 V617F+ Myelofibrosis Translational Diligence","description":"Synthesizes JH2 pseudokinase allosteric selectivity (PDB 4FVQ/4FVR) vs pan-JAK1/2 JH1 ATP-site inhibition failure modes, active clinical trials (INCB160058 NCT06313593, AJ1-11095 NCT06343805, INCA033989 NCT06034002, pelabresib NCT04603495, imetelstat NCT04576156), and single-cell marrow datasets (GSE144568, GSE156644).","tags":["myelofibrosis","JAK2-V617F","JH2","CALR","clinical-trials"],"examples":["Explain JH2 vs JH1 selectivity in JAK2 V617F myelofibrosis and active NCT trials."],"inputModes":[],"outputModes":[]},{"id":"autoimmune-myelofibrosis-iron-triage","name":"Autoimmune Myelofibrosis (AIMF) & Iron Overload Positive-Control Triage","description":"Contrasts clonal PMF against reversible JAK2-negative lupus/autoimmune myelofibrosis (74-80% marrow fibrosis reversal MF-2/3 -> MF-0/1 within 8-16 weeks on glucocorticoids/rituximab/mycophenolate) and dual transfusional + IL-6 -> STAT3 -> hepcidin (HAMP) -> ferroportin (SLC40A1) iron overload.","tags":["autoimmune-myelofibrosis","AIMF","lupus","SLE","hepcidin","iron-overload","fibrosis-reversal"],"examples":["How does JAK2-negative autoimmune myelofibrosis with lupus suspicion and iron overload differ from triple-negative PMF?"],"inputModes":[],"outputModes":[]},{"id":"non-dilutive-grant-stacking","name":"Orphan Disease Non-Dilutive Capital & 90-Day Diligence Roadmaps","description":"Maps NIH/NCI SBIR/STTR, ARPA-H, MPN Research Foundation, LLS Therapy Acceleration Program (TAP), CDCN, and FDA Orphan Drug incentives alongside 30/60/90-day validation plans.","tags":["grants","SBIR","ARPA-H","non-dilutive","orphan-drug"],"examples":["Retrieve a 90-day diligence plan and non-dilutive grant stack for a myelofibrosis AI drug repurposing team."],"inputModes":[],"outputModes":[]},{"id":"stress-test-orphan-hypothesis","name":"Stateless Translational & Venture Hypothesis Red-Team Oracle","description":"Executes an 8-rule translational & venture stress-test combining live OpenTargets v4, ClinicalTrials.gov v2, and PubMed lookups with Myelofibrosis & Orphan failure-mode checks (spleen-only SVR35 endpoint traps, reversible ANA+ Autoimmune Myelofibrosis AIMF mimicry, conserved JH1 WT JAK2 toxicity vs JH2 V617F allosteric selectivity, hepcidin mimetic vs suppressor polarity, trial crowding, zero-wet-lab CRO feasibility, and FY2026 FDA Orphan unit economics).","tags":["stress-test","red-team","myelofibrosis","JH2","AIMF","hepcidin","clinical-trials","orphan-drug"],"examples":["Stress-test a spleen-only SVR35 pan-JAK inhibitor in triple-negative myelofibrosis.","Red-team an ACVR1/hepcidin-lowering combination vs rusfertide in anemic myelofibrosis."],"inputModes":[],"outputModes":[]},{"id":"query-myelofibrosis-molecular-apis","name":"Queryable Myelofibrosis Gene Signatures, Structural Pockets & Cohort Comparison APIs","description":"Queries curated Myelofibrosis/AIMF/iron gene signatures (/api/gene), JAK2 JH2/JH1 & CALR structural pockets (/api/pocket), side-by-side cohort comparisons (/api/compare), and live ClinicalTrials.gov v2 Myelofibrosis catalyst calendars (/feeds/catalysts.json & /feeds/myelofibrosis-catalysts.ics).","tags":["gene-signatures","structural-biology","PDB","JAK2-JH2","HAMP","catalysts","cohort-comparison"],"examples":["GET /api/gene?symbol=HAMP or GET /api/gene?cohort=aimf","GET /api/pocket?pdb=4FVQ or GET /api/compare?a=jak2-myelofibrosis&b=autoimmune-myelofibrosis"],"inputModes":[],"outputModes":[]},{"id":"submit-research-finding-or-benchmark","name":"Two-Way Research Signal & MyelofibrosisBench-v1 Score Contribution","description":"Accepts zero-PII CC-BY-4.0 translational findings, dataset leads, or MyelofibrosisBench-v1 benchmark scores over A2A (prefix message with 'submit finding:', 'submit signal:', 'contribute:', or 'benchmark score:') or POST /api/feedback, surfacing opt-in benchmark scores on GET /api/leaderboard.json.","tags":["contribute","benchmark","MyelofibrosisBench-v1","leaderboard","open-science","two-way-a2a"],"examples":["submit finding: New scRNA-seq dataset showing elevated HAMP/IL-6 macrophage iron retention in ANA+ AIMF.","benchmark score: MyelofibrosisBench-v1 model=my-agent accuracy=86.7% keyword=90.0% composite=88.4%"],"inputModes":[],"outputModes":[]},{"id":"raretxbench-self-eval","name":"RareTxBench-v2.0 One-Call Self-Benchmarking Challenge","description":"Run a 1-call RareTxBench-v2.0 self-benchmark challenge (152 test items across 5 suites: raw_bio_compute, protocol_audit, bio_delta_live, open_frontier, and MCQ-100). Send 'benchmark challenge' over POST https://api.rare-disease-atlas.workers.dev/a2a to receive an unspoiled 3-item live self-test pack with exact grading instructions, or submit full predictions directly to POST https://api.rare-disease-atlas.workers.dev/api/grade-benchmark to appear on https://api.rare-disease-atlas.workers.dev/api/rare-tx-leaderboard.json.","tags":["RareTxBench-v2.0","self-eval","benchmark","leaderboard","raw_bio_compute","protocol_audit","bio_delta_live","open_frontier","MCQ-100"],"examples":["benchmark challenge","run raretxbench","self-eval"],"inputModes":[],"outputModes":[]}],"provenance":[{"source":"lists","first_seen":"2026-11-22T14:47:42.790717+00:00"}],"recent_probes":[{"fetched_at":"2026-11-22T14:47:42.790717+00:00","ok":true,"status_code":200,"error":null,"elapsed_ms":59,"live_responds":true}],"catalog_attestation":null,"operator_revenue_evidence":{"evidence_class":"operator_submitted","authenticity":{"rung":"no_operator_evidence","rank":0,"why":"No verifiable operator evidence has been submitted for this agent.","thresholds":{"min_independent_payers":3,"min_verified_usd":25.0},"engine_table":"agent_authenticity","merge_rule":"max(existing_rank, rank)"},"metric_metadata":{"provenance":"operator_submitted_evidence","confidence":"attested","coverage":{"numerator":0},"as_of":"2026-11-22T17:50:22.465677+00:00","definition":"Revenue proofs submitted by the verified owner and re-checked by Agenstry against the settlement chain or the operator's own Stripe account. Only independently confirmed proofs are counted."},"counts":{"retained":0,"verified":0,"unverifiable":0},"verified":{"gross_usd":0.0,"transactions":0,"independent_payers":0},"detail_url":"https://agenstry.com/api/agents/api.rare-disease-atlas.workers.dev/evidence","dispute_url":"https://agenstry.com/agents/api.rare-disease-atlas.workers.dev/dispute"},"verification_history":[]}